1. Introduction and Background
==============================

Since antiquity \[[@r1-2382740]\], the relationship between disease and birth seasonality was described, pondered and studied. Of particular interest to modern researchers is the relationship between developmental seasonality (using birth month as a proxy) and disease risk. The recent expansion in Electronic Health Records (EHRs) usage throughout the United States of America has enabled researchers to conduct diverse high-throughput exploratory analyses \[[@r2-2382740] [@r3-2382740] [@r4-2382740]--[@r5-2382740]\]. Recently, we developed and conducted a Season-Wide Association Study (SeaWAS), to systematically identify dependencies between birth month and disease risk using EHRs \[[@r6-2382740]\]. The initial study found disease-birth month associations \[[@r6-2382740]\], however it did not provide any molecular explanation for the dependency.

Recently, Dopico *et al.* demonstrated that gene expression can vary seasonally \[[@r7-2382740]\]. Additionally, we know that many biological compounds can vary seasonally in humans \[[@r8-2382740] [@r9-2382740] [@r10-2382740]--[@r11-2382740]\]. Therefore, we decided to develop an algorithm that uses existing data repositories containing genetic information for various disease states and Seasonally Varying Biofactors (SVBs) to find genes potentially responsible for reported birth month dependent diseases (BMDDs). We hope to use these genes to uncover mechanisms behind birth month-disease relationships.

One well-studied BMDD is asthma. Several studies have linked asthma risk to birth month \[[@r6-2382740],[@r12-2382740]\] where birth month is a proxy for a perinatal environmental exposure. Environmental factors play a key role not only in asthma development but also in its progression. Others have demonstrated that asthma flare-ups are seasonally dependent \[[@r13-2382740],[@r14-2382740]\] and that genetic mechanisms are involved in this seasonal dependency \[[@r15-2382740]\]. Despite all the knowledge behind asthma seasonality and the role of perinatal exposures in regards to disease risk, we cannot easily point to a biological mechanism behind the birth month association. In part, the difficulty lies in the fact that \>1,200 genes have been implicated in asthma disease progression \[[@r16-2382740]\]. Because of the plethora of genes implicated in certain diseases, finding the potential genetic mechanisms underlying birth seasonality associations is non-trivial. This formed the motivation for our current study.

2. Materials and Methods
========================

Our framework combines data from three public data repositories: PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>), DisGeNET (<http://www.disgenet.org>) \[[@r16-2382740]\] and the Gene Ontology (GO - <http://geneontology.org>). **[Figure 1](#f1-2382740){ref-type="fig"}** illustrates the overall framework approach. Each step is described in more detail in the sections that follow.

2.1 Assembling Data Sources from Existing Data Repositories
-----------------------------------------------------------

### 2.1.1 Develop List of Seasonally Varying Biofactors (SVBs)

Using PubMed, we searched for SVBs in humans (*Homo sapiens*). All non-humans (e.g., rats, geese, and even non-human primates) were excluded. While we required that the studies involve humans, we ignored the human state (e.g., post/pre menopausal, old/young). **[Figure 2](#f2-2382740){ref-type="fig"}** contains an example of two SVBs extracted from a study by Meier *et al.* \[[@r17-2382740]\] demonstrating the seasonality of parathyroid hormone (PTH) and vitamin D (specifically calcifediol). In **[Figure 2](#f2-2382740){ref-type="fig"}**, we can see that PTH tends to be higher in the winter months (Jan-Mar) while vitamin D is noticeably higher in the late spring/summer months (Jun-Aug).

To develop a list of literature-backed SVBs, we first queried PubMed with the query: returning 4,091 articles. We then added a species filter (humans) and a language filter (English), which reduced the results set down to 3,627 articles.

We are interested in SVBs and not disease flare-ups (e.g., asthma exacerbations occur seasonally). Therefore, we decided to modify the query to also include the compound. We then ran this for a large variety of compounds (e.g., vitamin D, lactic acid, eosinophils, neutrophils, estrogen, testosterone) to retrieve articles related to their seasonality or lack thereof.

We then read through the resulting abstracts to determine if the compound was accurately found, and to remove any non-human studies that managed to pass the earlier filter. After these initial checks, we determined if seasonal variation was found or not found by the study.

### 2.1.2 Develop List of Birth Month Dependent Diseases (BMDDs)

Previously, a curated reference set of BMDDs was assembled to assess the quality of SeaWAS results \[[@r6-2382740]\]. To derive this reference set, we extracted all articles from PubMed using the term "birth month" and one additional article referenced from a located article (156 articles total). After manually reviewing all articles, we identified 92 relevant articles where birth month was used to study disease risk as a proxy for an environmental exposure. Each article was manually classified regarding whether they found or failed to find an association between the disease of interest and birth month. We then mapped these diseases to EHR-extractable conditions and found that 19 diseases reported in the literature could be mapped including 16 positively associated and 3 not associated with birth month (\<50% literature support for an association with birth month). Because we wanted a list of BMDDs with at least 1 publication supporting the relationship between birth month and disease risk, we extended the original list to include the 12 novel findings from SeaWAS \[[@r6-2382740]\]. We provide this list with the supplemental information available on figshare. We will use the phrase 'see supplement' throughout this paper and we are referring to figshare accessible via: [figshare.com/s/b47610ea62d111e5b56406ec4bbcf141](http://figshare.com/s/b47610ea62d111e5b56406ec4bbcf141)

### 2.1.3 DisGeNET

We mapped each SVB to a disease involving dysregulation of a SVB because DisGeNET only contains genes associated with disease states. For example, vitamin D is an SVB. Hence vitamin D deficiency was used as one of the diseases involving the SVB vitamin D. All genes implicated via association studies in the disease of vitamin D deficiency were used as vitamin D genes. To match SVBs to diseases in DisGeNET, we performed substring matching to the SVB query term. In some cases, we had to modify the SVB search term used. We also did this to ensure that SVBs such as vitamin C (also known as ascorbic acid) were mapped properly. A list of SVBs and the exact query terms used for extracting genes from DisGeNET is included with the supplement. We include examples in **[Table 1](#t1-2382740){ref-type="table"}** for explanatory purposes along with example diseases and example genes implicated in those diseases for each SVB in **[Table 1](#t1-2382740){ref-type="table"}**. However, these examples are not exhaustive.

Additionally, we mapped our list of BMDDs to diseases in DisGeNET. We did this using approximate string matching similar to above. As this is a proof-of-concept of our framework, we randomly chose 7 BMDDs for this analysis provided they spanned the distribution of number of distinct genes. The seven BMDDs and their query terms used in DisGeNET are given in **[Table 2](#t2-2382740){ref-type="table"}**. We only used 7 BMDDs because we wanted to test the feasibility of our framework and algorithm. Note the number of distinct genes involved in each disease varies largely from 21 genes (reproductive performance) to 1253 genes (asthma). We randomly selected the BMDDs with this one constraint.

2.2 BMDD-SVB Pair Enrichment Algorithm
--------------------------------------

We developed an algorithm to uncover BMDD-SVB pairs that were enriched using their respective gene sets. The first step was the creation of an empirical null distribution for each disease. For each BMDD, we randomly extracted genes from DisGeNET (of the same size as the number of genes for that BMDD). Therefore, 1,253 distinct genes would be randomly pulled from DisGeNET for the empirical null distribution for asthma. However, for reproductive performance only 21 genes would be randomly pulled. We calculated the overlap between the SVB and the random gene set. We iterated through this sampling protocol 100 times and then an overall average overlap was computed. Fisher's exact test was performed between the true BMDD-SVB pair and the random average overlap computed above (**[Table 3](#t3-2382740){ref-type="table"}**). Bonferroni correction was applied to adjust for multiple comparisons since each SVB was compared to each BMDD.

2.3 Restrict to Genes Involved in Developmental Processes
---------------------------------------------------------

We aim to explore the contribution of birth month variance on lifetime disease risk. We are especially interested in genes involved in developmental processes, as these are most likely to contribute to a prenatal/perinatal contribution to increased disease risk due to environmental exposures around birth month. Using the Gene Ontology (GO), we restricted the gene set to only include those genes involved in developmental processes. We retained only those genes with at least one GO term containing 'develop' in its annotation term description. So for example, if a gene contained the term 'positive regulation of hair follicle development' or 'embryonic placenta development' it was retained in our analyses. This further reduced the gene set to about 30% of the size (for asthma, 439 asthma genes were enriched in asthma-SVB pairs and only 140 of those genes also had at least 1 developmental GO term).

2.4 Construct Bi-Partite Networks
---------------------------------

To visualize the results, we created bi-partite networks \[[@r18-2382740]\] for each SVB. BMDDs are included if they are enriched for overlapping genes with the SVB of interest. Each SVB (shown on the left side of the network) is linked to BMDDs (shown on the right side of the network) that are enriched in overlapping genes that are depicted in the middle portion of the graph. Only genes with a developmental GO process are included in the graph. We used DAVID \[[@r19-2382740],[@r20-2382740]\] to annotate the genes and identify functional gene modules. Network visualization was performed using Cytoscape \[[@r21-2382740]\].

3. Results
==========

3.1 Using Existing Data Repositories to Assemble Key Datasets
-------------------------------------------------------------

### 3.1.1 Seasonally Varying Biofactors (SVBs)

Our original search returned 3,627 articles related to seasonal variation in humans. Therefore, we included additional query terms for biological compounds such as hormones, vitamins, and immune-related cells that are thought to vary seasonally. This allowed us to identify 22 SVBs that are known to vary seasonally in humans. We also found 2 compounds (Homocysteine and Glutaric acid) that are not known to vary seasonally and one that varies seasonally in animals (Corticosterone) but with no human studies currently. We focused on the 22 SVBs that are confirmed to vary seasonally in humans by published studies indexed by PubMed. We used these as input for the enrichment algorithm. **[Table 4](#t4-2382740){ref-type="table"}** contains the references supporting the seasonal relationship and references that refute the relationship, if any exist.

### 3.1.2 Birth Month Dependent Diseases (BMDDs)

We combined results from our SeaWAS study with a carefully curated set of diseases related to birth month that we developed previously. This file is available with the supplement and includes the PubMed ID, publication year, disease area (high-level disease category), and a binary variable indicating whether the study found or failed to find the association. In this feasibility study of the algorithm's framework, we used 7 randomly chosen BMDDs with one constraint: that the number of distinct disease genes differed largely. For example, 21 genes were implicated in reproductive performance while 1253 genes were implicated in asthma.

### 3.1.3 DisGeNET

SVBs and BMDDs were mapped to DisGeNET to extract genes associated with each SVB and BMDD. Examples of the extraction process are given in methods **[Tables 1](#t1-2382740){ref-type="table"}** and [**2**](#t2-2382740){ref-type="table"}. For this proof-of-concept, we ran the DisGeNET extraction on 7 random BMDDs with different gene set sizes. We also used DisGeNET to extract the genes related to the 22 SVBs given in **[Table 4](#t4-2382740){ref-type="table"}** (folate and folic acid are counted as separate SVBs but merged under vitamin B9 in **[Table 4](#t4-2382740){ref-type="table"}**).

3.2 Enrichment Results
----------------------

Our enrichment algorithm investigates the overlap among gene sets from the BMDD and each SVB. It compares this overlap to an average across 100 randomly generated gene sets of the same size (i.e., number of genes) as the particular BMDD of interest. The average overlap score from the 100 random sets is compared against the actual number to determine significance using Fisher's exact test. We adjusted the p-values using the Bonferroni correction method. We then ranked each significant BMDD-SVB pair by the ORs. Results are shown in **[Table 5](#t5-2382740){ref-type="table"}** with the top three associations in bold.

The top SVBs associated with each BMDD are biologically intuitive. Cardiovascular disease is known to involve vitamin K regulation with the anti-coagulant drug warfarin targeting the well-studied vitamin K gene: VKORC1. The two top SVBs related to asthma (a known immune-related condition) are also immune related: eosinophils and neutrophils \[[@r22-2382740]\]. Atrial fibrillation's top hits are calcium related and atrial fibrillation is associated with increased calcium release from the sarcoplasmic reticulum \[[@r23-2382740]\].

3.3 Restrict to Genes Involved in Developmental Processes
---------------------------------------------------------

We reduced the number of genes in our results set by restricting the gene sets to only include those involved in at least one developmental process using GO annotations. This was primarily because of our interest in genes that are involved in developmental processes and therefore may play a role in birth month associations. This drastically reduced our results set as shown in **[Table 6](#t6-2382740){ref-type="table"}**.

**[Table 6](#t6-2382740){ref-type="table"}** illustrates how the algorithm started with 1,253 genes associated with Asthma as extracted from DisGeNET. Because asthma is also known to be associated with birth month and a BMDD, we ran our algorithm to find overlapping genes between asthma and SVBs where the overlapping genes were enriched. This reduced the number of genes potentially involved in a seasonally varying process at birth down to 439 genes from 1253. We then restricted these 439 genes to only include genes known to be involved in some developmental process using GO term annotations. This further reduced the number of genes down to 140. Therefore, only 11.2% of asthma-related genes are potentially involved in developmental processes related to SVBs that could potentially lead to birth month-related effects.

3.4 Developmentally Expressed Genes Link SVBs to BMDDs in Biological Networks
-----------------------------------------------------------------------------

Our algorithm produces output containing each BMDD, the enriched SVBs and the overlapping genes that are developmentally expressed between the BMDD and the SVB. A file containing tuples of BMDD, SVB, and gene is available in the supplement.

For illustrative purposes, we show three SVB networks from our feasibility study: two immune cells (eosinophil and neutrophil) and one hormone (parathyroid hormone). Full resolution images are available with supplemental information on figshare at [figshare.com/s/b47610ea62d111e5b56406ec4bbcf141](http://figshare.com/s/b47610ea62d111e5b56406ec4bbcf141). The immune cells are shown in **[Figure 3](#f3-2382740){ref-type="fig"}**, the SVB is represented by a triangle, the BMDD is represented by a square and circles represent the overlapping genes. Cluster annotations from DAVID are shown above or near each cluster. In the neutrophil network (**[Figure 3A](#f3-2382740){ref-type="fig"}**) there are clusters involving blood vessel development, response to an organic substance, positive regulation of nitrogen compound metabolic processes, regulation of cell proliferation and embryonic development / birthing. In **[Figure 3B](#f3-2382740){ref-type="fig"}**, the largest cluster includes genes related to the immune response (as expected). Other clusters are for neuron development, tube development (e.g., neural, endothelial tubes), response to sterol hormone synthesis and insulin stimulus. The same 5 BMDDs are involved in both: attention deficit hyperactivity disorder (ADHD), cardiomyopathy, atrial fibrillation, cardiovascular disease, and asthma. Eosinophils and neutrophils are in the top 3 most enriched SVBs for both asthma and ADHD (**[Table 5](#t5-2382740){ref-type="table"}**). Its possible that the genes involved in neuron development is responsible for the ADHD - Eosinophil relationship (**[Figure 3B](#f3-2382740){ref-type="fig"}**).

**[Figure 4](#f4-2382740){ref-type="fig"}** shows the network for parathyroid hormone (PTH). There are three main genetic processes involved: positive regulation of the development process, receptor linked signal transduction, and response to hormone stimulus. Not only is parathyroid hormone a hormone, but it also is involved in regulation or other hormones. **[Figure 2](#f2-2382740){ref-type="fig"}** illustrates the somewhat anti-correlated relationship PTH has with vitamin D that has been described by others \[[@r17-2382740]\]. Both PTH and vitamin D are hormones that regulate each other through complex mechanisms. Positive regulation of the development process to also be enriched in this network connecting PTH and BMDD this fits with the involvement of this SVB with a contribution to disease risk that is due to birth month.

4. Discussion
=============

4.1 Value of a High-throughput Birth Month-Disease Dependency Genetic Algorithm
-------------------------------------------------------------------------------

The relationship between genes, environment and disease has been discussed by medical researchers since the early days of genetics \[[@r43-2382740]\]. Because the relationship between genes and the environment is complex, researchers originally investigated single environmental exposures and how those exposures influenced disease risk via genetic changes \[[@r44-2382740]\]. An improvement on this original concept was the development of the Environment-Wide Association Study (EWAS) that explored a large variety of environmental exposures (not just one as was done previously) and then explored how those exposures effected one single disease: Type 2 Diabetes \[[@r45-2382740]\]. While an improvement over the work that was conducted previously, EWAS was still limited to exploring one disease at a time.

Our SeaWAS study revealed multiple birth month-disease dependencies (called BMDDs). Additionally, 92 other articles revealed additional information on BMDDs. None of these epidemiological studies sheds light on the genetic underpinnings of BMDDs as they focus primarily on observational data. Therefore, a method was required that could investigate diverse environmental triggers across a plethora of diseases and disease types (e.g., reproductive, mental, immune, and respiratory diseases). To address this gap, we developed an algorithmic framework to uncover enriched SVBs related to BMDDs.

In addition to finding SVBs enriched in BMDDs, we also explore the overlapping genes implicated in both the SVB and the BMDD. We limit our investigation to only those genes that are known to be involved in developmental processes to hone in on those genes that are potentially responsible for birth month disease dependencies. We describe in this paper our exploration of 7 BMDDs and we highlight 3 biological networks related to key SVBs and the BMDDs they potentially modulate.

4.2 Highlighting One Well-Studied Disease: Asthma
-------------------------------------------------

The top SVBs enriched for asthma were eosinophil (OR=23.545), neutrophil (OR=7.601) and vitamin D (OR=7.597) (**[Table 5](#t5-2382740){ref-type="table"}**). The relationship between eosinophils (key cells in the immune response) and asthma is well known and studied \[[@r46-2382740]\]. At the same time asthma exacerbations and underlying gene expression changes are also known to vary seasonally \[[@r15-2382740]\]. As revealed by our framework, there is also literature support for a relationship between eosinophil changes and season \[[@r35-2382740],[@r37-2382740],[@r38-2382740]\]. Our framework revealed 42 genes in common between asthma and eosinophils that are also involved in developmental processes (the entire eosinophil network is shown in **[Figure 3B](#f3-2382740){ref-type="fig"}**). The immune response was the key functional process involved in this network along with neuron development (which could help to explain the interesting relationship between eosinophils and ADHD in our network).

**[Table 5](#t5-2382740){ref-type="table"}** reveals an interesting relationship between asthma and ADHD: they both share eosinophils and neutrophils among their top 3 SVB enrichments (asthma also has vitamin D and ADHD has parathyroid hormone---which are also related to each other). When we investigated the biological network (**[Figure 3B](#f3-2382740){ref-type="fig"}**), the enrichment in neuron development genes is revealed. Importantly, asthma patients are known to be at increased risk for developing ADHD and this increased risk was observed even after adjusting for urbanization and comorbid allergic diseases suggesting an underlying etiology behind the two diseases \[[@r47-2382740]\]. Others have also studied the relationship between asthma and ADHD \[[@r48-2382740]\] without uncovering a clear genetic/biological mechanism for the relationship.

Studies show that fetal outcomes following an environmental exposure can vary based on the trimester of exposure. Specifically there have been studies related to famine \[[@r49-2382740]\] and air pollution \[[@r50-2382740]\]. Our SeaWAS study found both ADHD and asthma to be associated with birth month, but the relative risk curves were different (ADHD risk peaked in Nov. while asthma risk peaked in Sept.) \[[@r6-2382740]\]. These differences in birth month risk suggest the possibility of a trimester effect (if the exposure is constant for both diseases). Gelardi *et al.* found that eosinophil cell counts increased almost four-fold in March when compared to any other month (data from Southern Europe) \[[@r35-2382740]\]. Hence, babies born in November would be experiencing their first trimester during March while babies born in September would be in their second trimester and a trimester-exposure effect of eosinophils on development could be partially responsible. Importantly, our framework enables researchers to construct biological networks that connect complex associations between SVBs and BMDDs through their shared underlying genetic pathways. This enables researchers to formulate and test hypotheses behind disease etiology and progression.

4.3 Limitations and Future Work
-------------------------------

Our study is limited by the information contained and available on PubMed regarding biofactors that vary seasonally (SVBs) and BMDDs. Therefore, neither of these lists is fully complete as there may be other studies not reported in PubMed, studies not translated into English and so forth that would prevent us from using their findings in our framework. Our initial query to PubMed returned 3,627 articles related to seasonal variation in humans. Because we were primarily interested in biological compounds that vary seasonally (such as hormones, vitamins, immune cells), we added additional query terms (as specified in the methods section of the paper). Ideally we would manually review all 3,627 articles but this was not feasible, therefore we may be missing some lesser-known SVBs. Future work includes expanding this work beyond the proof-of-concept presented here to all BMDDs and SVBs. This includes developing a master list of biofactors. Additionally, the fetal-maternal barrier warrants further investigation as the placenta is known to be susceptible to environmental effects \[[@r51-2382740]\]. Incorporating knowledge on the epigenetics of the placenta could help with understanding the underlying disease mechanism \[[@r51-2382740]\].

5. Conclusion
=============

We present a framework that combines existing data repositories (PubMed, GO, and DisGeNET) to uncover biological mechanisms underlying birth month - disease dependencies (BMDDs) using known Seasonally Varying Biofactors (SVBs). Our framework allows us to link 1) epidemiological data on birth month-disease relationships and 2) genetic data on gene-disease associations recorded in existing public data repositories. Our algorithm finds enriched BMDD-SVB pairs using the genes involved in both the disease and the SVB. We then investigate the overlapping genes in these enrichments and trim away genes not known to be involved in developmental processes using GO annotations. Our framework produces a bipartite network that connects enriched SVBs with BMDDs through their overlapping developmental gene sets. Thus allowing us to form biological hypotheses around the genetic mechanisms underlying birth month-disease dependencies. As a proof-of-concept, we present results from 7 BMDDs across all identified known SVBs. We show biological networks from 3 SVBs while highlighting asthma.
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![SVBs (parathyroid hormone and calcifediol) measured by Meier *et al.* 2004. Best-fit lines were applied and slight non-significant anti-correlation was observed (r=−0.303, p=0.338).](2382740f2){#f2-2382740}

![Immune Cell Bi-Partite Networks Connecting SVBs to BMDDs Via Overlapping Genes Involved in Developmental Processes. Full resolution images are available on figshare.](2382740f3){#f3-2382740}

![Network Connecting Parathyroid Hormone with BMDDs Via Overlapping Genes Involved in Developmental Processes. Full resolution images are available on figshare.](2382740f4){#f4-2382740}

###### 

Examples of SVBs and DisGeNET query terms used to extract SVB-related diseases and genes potentially involved in perturbation of SVBs

  SVB                   SVB query term used   Example Disease Names                                                            Example Genes Implicated
  --------------------- --------------------- -------------------------------------------------------------------------------- ----------------------------
  Vitamin D             "Vitamin_D"           Vitamin D Deficiency, Rickets Hereditary Vitamin D-Resistant                     DHCR7, VDR
  Parathyroid hormone   "Parathyroid"         Pseudo-hypoparathyroidism, Parathyroid Neoplasms                                 GNAS, CDC73
  Vitamin C             "ascorbic acid"       Ascorbic Acid Deficiency                                                         GSTK1, HP, SLCO6A1
  Vitamin K             "Vitamin_K"           Vitamin K Deficiency, Vitamin K Dependent Clotting Factors Combined Deficiency   GGCX, VKORC1, F7
  Neutrophil            "Neutrophil"          Neutrophil Actin Dysfunction, Hereditary Neutrophilia                            PARP1, CYBA, CSF3R
  Eosinophil            "Eosinophil"          Eosinophilia, Hyper-eosinophilic Syndrome                                        IL5, FIP1L1, PDGFRA
  Hemoglobin            "Hemoglobin"          Hemoglobinopathies, Methemoglobinemia                                            HBB, CYP1A2, HBA1
  Estrogen              "Estrogen"            Oestrogen deficiency, Estrogen Resistance                                        ESR1, RBBP4, BCAR1, PPP2CA

###### 

BMDDs included in proof-of-concept along with query terms, example genes implicated and counts of genes involved in BMDD

  BMDD                         BMDD query term used           Example Genes Implicated                No. Distinct Genes
  ---------------------------- ------------------------------ --------------------------------------- --------------------
  Asthma                       "Asthma"                       SCGB1A1, TNF, CCL11                     1253
  Attention Deficit Disorder   "attention_deficit_disorder"   COMT, LPHN3, GRM5                       338
  Atrial Fibrillation          "Fibrillation"                 ACE, NOS3, KCNE2, SELE, VWF             318
  Reproductive Performance     "Reproductive"                 BRCA1, BRCA2, TLR4, ESR1, MBL3P         21
  Cardiovascular Disease       "Cardiovascular"               ACE, APOB, LPL, MTHFR                   775
  Cardiomyopathy               "Cardiomyopathy"               CSRP3, TTN, DES, TMPO, VCL              717
  Mitral Valve Disorder        "mitral_valve"                 FBN1, AGTR1, FBN2, NPPB, PLAU, COL3A1   82

###### 

The Structure of the Enrichment Algorithm: Each BMDD-SVB Pair was Compared Against a Randomly Generated BMDD-SVB Pair Specific for that BMDD

                                                                 No. of BMDD Genes Per SVB   No. Genes Per SVB - No. BMDD Genes Per SVB
  -------------------------------------------------------------- --------------------------- --------------------------------------------
  Actual BMDD-SVB Pair                                           A                           B
  Randomly Generated[^\*^](#tfn1-2382740){ref-type="table-fn"}   C                           D

Random was the average across 100 random gene set extractions from DisGeNET using the same number of genes as the BMDD

###### 

Biofactors With Seasonal Dependencies Extracted from the Literature

                                                                                            Seasonal Relationship                                            
  ------------------------------------ ---------------------------------------------------- ---------------------------------------------------------------- --------------------
  **Hormone**                                                                                                                                                
  Parathyroid Hormone (PTH)            PTH and vitamin D are slightly anti-correlated       \[[@r17-2382740],[@r24-2382740]\]                                
  Estrogen                             (modulated through Vitamin D)                        \[[@r25-2382740]\]                                               
  Estradiol                                                                                 \[[@r26-2382740]\]                                               
  Testosterone                         (modulated through Vitamin D)                        \[[@r25-2382740]\]                                               
  Progesterone                         (modulated through Vitamin D)                        \[[@r25-2382740]\]                                               
  **Vitamins/Minerals**                                                                                                                                      
  Vitamin A (retinol, beta-carotine)   Bitot eye spots are a sign of vitamin a deficiency   \[[@r9-2382740],[@r10-2382740],[@r27-2382740],[@r28-2382740]\]   
  Vitamin B9: Folate and Folic Acid                                                         \[[@r11-2382740],[@r29-2382740]\]                                
  Vitamin B12                                                                               \[[@r30-2382740]\]                                               
  Vitamin C (Ascorbic acid)                                                                 \[[@r9-2382740],[@r31-2382740],[@r32-2382740]\]                  
  Vitamin D                                                                                 \[[@r17-2382740],[@r24-2382740],[@r33-2382740]\]                 
  Vitamin E                                                                                 \[[@r9-2382740]\]                                                
  Vitamin K                            Vitamins K and D regulate osteocalcin                \[[@r33-2382740],[@r34-2382740]\]                                
  Calcium                                                                                   \[[@r17-2382740],[@r24-2382740],[@r33-2382740]\]                 
  Phosphate                                                                                 \[[@r33-2382740]\]                                               
  **Immune Cells**                                                                                                                                           
  Neutrophil                                                                                \[[@r35-2382740],[@r36-2382740]\]                                
  Eosinophil                                                                                \[[@r35-2382740],[@r37-2382740],[@r38-2382740]\]                 
  Basophil                                                                                  \[[@r38-2382740]\]                                               \[[@r37-2382740]\]
  **Other Cells/Metabolites**                                                                                                                                
  Hemoglobin                                                                                \[[@r39-2382740]\]                                               
  Uric                                 Uric acid                                            \[[@r40-2382740]\]                                               
  Creatine                                                                                  \[[@r41-2382740]\]                                               
  Lactic                               Lactic acid                                          \[[@r42-2382740]\]                                               

###### 

BMDD-SVB Enriched Overlapping Gene Sets Sorted by OR

  BMDD Disease         Enriched SVB                          OR              −log(p)[^\*^](#tfn2-2382740){ref-type="table-fn"}
  -------------------- ------------------------------------- --------------- ---------------------------------------------------
  **Asthma**           **Eosinophil**                        **23.545308**   **92.3610942**
                       **Neutrophil**                        **7.608800**    **41.7971736**
                       **Vitamin D**                         **7.597455**    **4.9508901**
                       Phosphate Gene Set 1 (Phosph)         6.787030        36.4156313
                       Hemoglobin                            6.684969        19.1382008
                       Uric                                  5.672420        12.1008132
                       Calcium Gene Set 2 (Calcinosis)       4.085383        5.4623019
                       Calcium Gene Set 1 (Calci)            3.511367        9.7828493
                       Phosphate Gene Set 2 (Phosphate)      5.095905        10.1171083
                       Parathyroid Hormone                   4.494405        23.8948578
  **ADHD**             **Eosinophil**                        **3.805091**    **5.2892789**
                       **Parathyroid Hormone**               **3.553309**    **11.9138662**
                       **Neutrophil**                        **3.308624**    **9.2041648**
                       Phosphate Gene Set 1 (Phosph)         3.302909        9.7728579
                       Calcium Gene Set 1 (Calci)            2.679110        7.5585981
                       Calcium Gene Set 2 (Calcinosis)       2.043983        7.1930726
  **Fibrillation**     **Calcium Gene Set 2 (Calcinosis)**   **12.287454**   **7.1930726**
                       **Phosphate Gene Set 1 (Phosph)**     **6.440454**    **9.7728579**
                       **Parathyroid Hormone**               **6.437664**    **11.9138662**
                       Calcium Gene Set 1 (Calci)            6.380333        7.5585981
                       Neutrophil                            6.252987        9.2041648
                       Eosinophil                            6.242087        5.2892789
  **Reproductive**     \-                                    \-              \-
  **Cardiovascular**   **Vitamin K**                         **45.187116**   **5.8861829**
                       **Folic Acid**                        **14.548556**   **6.5377502**
                       **Vitamin D**                         **13.319860**   **6.1949509**
                       Phosphate Gene Set 2 (Phosphate)      11.560768       23.1079644
                       Phosphate Gene Set 1 (Phosph)         9.246976        39.8563236
                       Uric                                  9.174204        17.0939677
                       Calcium Gene Set 2 (Calcinosis)       8.543921        13.0824611
                       Calcium Gene Set 1 (Calci)            8.492730        28.6820297
                       Neutrophil                            7.892360        28.6839072
                       Eosinophil                            6.946996        19.5349288
                       Hemoglobin                            6.384460        11.7733926
                       Parathyroid Hormone                   4.149517        13.8335245
  **Cardiomyopathy**   **Vitamin D**                         **10.145258**   **3.851662**
                       **Eosinophil**                        **8.923802**    **25.690966**
                       **Lactic**                            **8.159469**    **6.974233**
                       Hemoglobin                            7.666338        15.743251
                       Calcium Gene Set 2 (Calcinosis)       7.616024        10.981833
                       Neutrophil                            6.468582        21.428566
                       Phosphate Gene Set 1 (Phosph)         6.284259        22.014083
                       Calcium Gene Set 1 (Calci)            6.049040        16.056148
                       Uric                                  5.784556        6.909913
                       Parathyroid Hormone                   4.781197        16.279232
                       Phosphate Gene Set 2 (Phosphate)      4.342993        3.422636
  **Mitral Valve**     **Phosphate Gene Set 1 (Phosph)**     **16.780523**   **5.1995428**
                       **Calcium Gene Set 1 (Calci)**        **13.587347**   **3.2560223**

greater than 3.0 is significant after Bonferroni correction

###### 

Number of Genes Involved in BMDD That Are Potentially Involved in Birth Month Contribution to Disease is Drastically Reduced After Framework Is Applied

  BMDD             No. Distinct Genes (A)   No. of Overlapping Genes from Enriched BMDD-SVB Pairs (B)   No. of Genes from B Involved in Developmental Processes (C)   \% of Genes Potentially Involved in Birth Month Contribution Out of All BMDD Genes (C/A)
  ---------------- ------------------------ ----------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------------------
  Asthma           1253                     439                                                         140                                                           0.112
  ADHD             338                      63                                                          18                                                            0.053
  Fibrillation     318                      105                                                         45                                                            0.142
  Reproductive     21                       \-                                                          \-                                                            \-
  Cardiovascular   775                      302                                                         109                                                           0.141
  Cardiomyopathy   717                      250                                                         89                                                            0.124
  Mitral Valve     82                       24                                                          15                                                            0.183
